Study Summary
This trial compares OPEP therapy to IS in patients admitted for rib fractures.
Eligible Conditions
- Rib Fractures
- Respiratory Complications
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3 times daily, until FVC is >1.5 liters x 4 consecutive tests, or up to 4 weeks
Week 4
Time (hours) to stable forced vital capacity
Trial Safety
Phase-Based Safety
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Trial Design
2 Treatment Groups
Incentive spirometry
1 of 2
Oscillating Positive Expiratory Pressure Device
1 of 2
Active Control
Experimental Treatment
50 Total Participants · 2 Treatment Groups
Primary Treatment: Oscillating Positive Expiratory Pressure Device · No Placebo Group · N/A
Oscillating Positive Expiratory Pressure Device
Device
Experimental Group · 1 Intervention: Oscillating Positive Expiratory Pressure Device · Intervention Types: DeviceIncentive spirometry
Device
ActiveComparator Group · 1 Intervention: Incentive spirometry · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks
Who is running the clinical trial?
Monaghan Medical CorporationUNKNOWN
1 Previous Clinical Trials
150 Total Patients Enrolled
Poudre Valley Health SystemLead Sponsor
15 Previous Clinical Trials
690 Total Patients Enrolled
Julie Dunn, MDPrincipal Investigator - Trauma Research Medical Director
Poudre Valley Health System
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have at least one broken rib.